Jane Wardle Prevention and Early Diagnosis Prize
This prize recognises an individual at any career stage who has produced world-leading research in the field of prevention and early detection of cancer.
Researchers at any career stage in the fields of prevention or early diagnosis
TBA - Expected to be autumn 2019
TBA - Expected to be spring 2020
Make a nomination
The Jane Wardle Prize will be awarded annually to an outstanding cancer researcher nominated by his or her peers and selected by an international panel.
- Candidates should work in the broad research field relating to prevention or early detection of cancer
- Candidates must have produced international quality research outputs, and be committed to building their research career within the UK.
- Candidates cannot nominate themselves.
- Candidates need not be in receipt of funding from Cancer Research UK, or have been supported, either directly or indirectly, by Cancer Research UK.
- The Prize will be presented to an individual investigator.
Cancer Research UK is committed to promoting equality, diversity and inclusion. We’re seeking nominations from a diverse range of backgrounds for this Prize.
To nominate, the following materials must be submitted:
- A completed nomination form that includes a summary statement of no more than 2000 words, describing: the research accomplishment(s) of the candidate and the significance and impact of his/her research. Publications supporting these contributions may be directly referenced within the text.
- One letter of support from an expert in the field, who must come from outside the nominee's institution. This can be included with the nomination form or sent directly to Cancer Research UK at the email address below. The name of the referee should be included in the nomination form.
- The candidate's CV, including a list of their most relevant publications (up to a maximum of 10).
There is no restriction on how many candidates can be nominated by an individual scientist. There is also no restriction on the number of nominators writing nomination letters or signing a single nomination letter on behalf of a candidate.
Nominators are asked to maintain the confidentiality of the nomination process.
Nominations must be submitted electronically to email@example.com. Paper nominations will not be accepted. A nomination should not be considered submitted until Cancer Research UK has issued an email confirming this. Confirmations will be sent within five working days.
Please note that the deadline is final and we cannot accept nominations after 5 p.m. on the day of the deadline.
Winners of the Jane Wardle Prize
Prof Rebecca Fitzgerald
Title: 2018 winner
Organisation: University of Cambridge
Rebecca Fitzgerald is Professor of Cancer Prevention at the University of Cambridge, MRC Programme Leader at the MRC Cancer Unit, and Honorary Consultant at Addenbrooke’s Hospital. Our panel recognised Rebecca for her work in improving the early detection of oesophageal cancer, and in particular, developing the ‘Cytosponge’ tool for early diagnosis of Barrett’s oesophagus. With Cytosponge currently in testing in GP practices, the panel agreed that Rebecca’s unique contributions have had significant impact on the field and in the clinic.
The panel also highlighted Rebecca’s role as a leader and mentor in developing the community of oesophageal cancer researchers in the UK and worldwide. Rebecca has helped to unite a community of researchers around this hard-to-treat disease, in part through her role as co-organiser of the International Symposium on Oesophageal Cancer.
Prof Greg Rubin
Title: 2017 winner
Organisation: Newcastle University
Greg Rubin is Professor of General Practice and Primary Care at Newcastle University. Greg's work has focussed particularly on understanding primary care in the diagnosis of cancer, and has had substantial impact on healthcare policy and practice. Greg's major achievements include leading an influential evaluation of early detection policies, and on the roles of awareness and diagnostic intervals within primary care in cancer control, which led to changes in NICE guidelines. The panel commended Greg not only for his personal achievements, but also for his highly collaborative approach to research, and for his role as an educator, mentor and champion of the early diagnosis research community.
Dr Jo Waller
Title: 2016 winner
Organisation: University College London
Dr Jo Waller’s team, based at UCL, carry out pioneering research on the public perception of cervical screening and HPV testing and vaccination. Dr Waller’s work has had a clear clinical impact on the Cervical Screening Programme in England and has helped to understand screening non-participation and ways that women can be supported to attend.